2024 ACMT | Annual Scientific Meeting
Includes a Live In-Person Event on 04/12/2024 at 7:45 AM (EDT)
- Early bird pricing available!
- Non-member - Tier I - $950
- Non-member - Tier II - $650
- Non-member - Tier III - $550
- Non-member - Tier IV - $450
- Member - Tier I - $650
- Member - Tier II - $450
- Member - Tier III - $350
- Member - Tier IV - $250
- Regular Price after 02/20/2024 11:59 PM
- Non-member - Tier I - $1,050
- Non-member - Tier II - $750
- Non-member - Tier III - $650
- Non-member - Tier IV - $550
- Member - Tier I - $750
- Member - Tier II - $550
- Member - Tier III - $450
- Member - Tier IV - $350
2024 ACMT Annual Scientific Meeting
April 12-14, 2024
Omni Shoreham Hotel, Washington, DC
The ACMT Annual Scientific Meeting (ASM) is an opportunity for specialists in the field to gather together to learn from the cutting-edge research of their peers. In addition to all the networking and social opportunities that make our events so rich with engagement, this year ACMT is piloting concurrent sessions offering more educational content than ever before! These concurrent sessions will be divided into the following topical tracks of broad interest to the Medical Toxicology community: 1) Environmental & Occupational Medicine, 2) Addiction Medicine, 3) Diversity, Equity & Inclusion, and 4) Research.
Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person or watch them on-demand after the event.
ACMT has secured a discounted rate at the Omni Shoreham Hotel in Washington, DC for attendees of our 2024 ACMT Annual Scientific Meeting. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!
Accepting Abstract Submissions: September 1 - November 15, 2023
Early Bird Registration Opens: October 2, 2023
MTF Spadafora, Shannon, J&J Travel Award Deadlines: October 2, 2023
Becker Medal Deadline: October 27, 2023
Abstract Student/Resident and International Travel Awards Deadline: November 15, 2023 (Abstract deadline)
MedTox Shark Tank Research Forum application deadline: December 4, 2023
MedTox Case Panel application deadline: December 18, 2023
Abstract Notifications: Mid December 2023
Open Mic Competition application deadline: January 15, 2024
Early Bird Registration Ends: February 20, 2024
2024 ACMT: April 12-14, 2024
Please write to ACMT at firstname.lastname@example.org
This agenda is subject to change. All times listed are in local, Eastern Time Zone.
Friday, April 12, 2024
7:45 - 8:00 AM - Welcome & Introductions
8:00 - 9:00 AM - Platform Session 1
9:00 - 9:45 AM
Donovan Lectureship | Groundbreaking Research from NIDA Addressing the Challenges of the Opioid Epidemic
Nora D. Volkow, MD, Director, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Washington, DC
This lectureship is supported by the Medical Toxicology Foundation through the Ward and Ryan Donovan Memorial Fund. For more info, please visit: www.acmt.net/donovan-lectureship
9:45 - 10:45 AM
Chemical Defense: Assessing and Optimizing Local Responses
Mark Kirk, MD, Senior Advisor, Chemical Defense, DHS Countering Weapons of Mass Destruction, Department of Homeland Security, Washington, DC
The Past, Present, and Future of Contributions of the United States Army Medical Research Institute of Chemical Defense to Chemical Casualty Care
Daniel Nogee, MD, MHS, Medical Toxicologist, Chemical Casualty Care Division, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD
10:45 - 11:45 AM - Poster Session 1
10:55 - 11:35 AM - Moderated Poster Forum 1
11:45 - 1:00 PM - Break / Committee Meetings
|Tracks||1:00-1:30 PM ET - Concurrent Sessions|
Pick one to attend live, watch the others on-demand after (if available)
|Environmental & Occupational
Harmful Algal Blooms (HABs): What Poison Centers and Medical Toxicologists Should Know
Brett E. Johnson, MD, Emergency Medicine Physician, UMass Memorial Medical Center, Worcester, MA
Medication for Opioid Use Disorder Trajectory Phenotypes: Development of a Risk Stratification and Prediction Framework Using Urine Toxicology and EHR Data
Albert Burgess-Hull, PhD, Head Data Scientist, MATClinics, University of Maryland, Baltimore, MD
The Toxic Past and Present of Redlining and Racial Segregation
Sean D. McCann, MD, Assistant Professor of Clinical Emergency Medicine and Medical Toxicology, University of Illinois Chicago, Chicago, IL
Researchers, Do You Even R? Getting Started with Managing and Visualizing Toxicology Data in R
Hannah Spungen, MD, MPH, Toxicology Fellow, Banner University Medical Center-Phoenix, Phoenix, AZ
1:30 - 1:40 PM ET - Break / Transition Time
|Tracks||1:40-2:10 PM ET - Concurrent Sessions|
Pick one to attend live, watch the others on-demand after (if available)
|Environmental & Occupational
Mad About Manganese: Medical Toxicologists and Water Quality Standards
Richard Hamilton, MD, MBA, FACMT, FACEP, FAAEM, Professor and Chair of Emergency Medicine, Drexel University College of Medicine Philadelphia, PA
The Public Health Impact of Over-The-Counter Naloxone & Nalfamene
Michael Toce, MD, MS, FACMT, Assistant Professor of Pediatric and Emergency Medicine, Harvard Medical School, Boston, MA
The Good, Bad and Ugly: Drug Testing in Liver Transplant Evaluations
JoAn Laes, MD, FACMT, FASAM, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN
Translational Approach to Biomarker and Therapeutic Development in Environmental Toxicology
David Jang, MD, MSc, FACMT, Assistant Professor, University of Pennsylvania School of Medicine, Philadelphia, PA
2:10 - 2:20 PM ET - Break / Transition Time
|Tracks||2:20-2:50 PM ET - Concurrent Sessions|
Pick one to attend live, watch the others on-demand after (if available)
|Environmental & Occupational
Do You Really Know IARC? Why IARC Determinations Aren’t Clear Cut, and When They Result in Controversy
John Downs, MD, MPH, Associate Professor and Associate Program Director, Occupational & Environmental Medicine Residency, Uniformed Services University, Bethesda, MD
Psilocybin and the Treatment of Substance Use Disorder
Albert Garcia-Romeu, PhD, Assistant Professor, Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD
Toxicology Practice and Gender and Sexual Minorities
Sarah Weiss, MD, MBS, Director of Medical Toxicology, Reading Hospital, Tower Health, Sinking Spring, PA
Translational Research from Laboratory Bench to Clinical Practice: Digoxin Poisoning
Betty Shuk Han Chan, MBBS, PhD A/Prof, Prince of Wales Hospital, Sydney, Australia
2:50 - 3:00 PM ET - Break / Transition Time
|Tracks||3:00-3:30/45 PM ET - Concurrent Sessions|
Pick one to attend live, watch the others on-demand after (if available)
Environmental & Occupational
Testing and Counseling on Polyfluoroalkyl Substances (PFAS) exposure in the Medical Toxicology Clinic
Nicholas Erick Nacca, MD, Assistant Professor of Emergency Medicine, University of Rochester Medical Center, Rochester, NY
Moderator: Michael Holland, MD, FACMT, FAACT, FEACCT, FACOEM, FACEP, SUNY Upstate Medical University, Syracuse, NY
Note: to accommodate additional speakers this session has been extended and will now be 45 min (3:00-3:45 PM ET)
Annual Review of Medical Toxicology Publications - Articles You May Have Missed from 2023-2024
Dan McCabe, MD, Director of the Division of Medical Toxicology & Associate Medical Director, University of Iowa & Iowa Poison Control Center, Iowa City, IAM/p>
Trauma-Informed Care for the Medical Toxicologist
Vinodinee L. Dissanayake, MD, MPH, Assistant Professor, Department of Emergency Medicine, Rush University Medical Center, Chicago, IL
Anatomy of Authorship
Mark Mycyk, MD, Editor in Chief; Research Chair, Journal of Med Tox; Cook County Health, Chicago, IL
3:30/45 - 5:00 PM - Break / Committee Meetings
5:00 - 6:00 PM - ACMT Annual Members Meeting and Awards Ceremony
6:00 - 8:00 PM - President's Reception
Saturday, April 13, 2024
7:45 - 8:00 AM - Morning Announcements
8:00 - 9:00 AM - Platform Session 2
9:00 - 9:45 AM
Panel | The East Palestine Disaster: Toxicological Considerations
Joseph Cocciardi, PhD, MS, FAIHA, CIH, CSP, REHS/RS, Founding Principal, Cocciardi and Associates, Inc.; Senior Health & Safety Professional, Pennoni, Mechanicsburg, PA
Michael Kosnett, MD, MPH, FACMT, Associate Clinical Professor, Department of Environmental & Occupational Health, University of Colorado School of Medicine and School of Public Health, Denver, CO
Charles McKay, MD, FACMT, Associate Medical Director, Connecticut Poison Control Center, University of Connecticut School of Medicine, Marlborough, CT
Anthony Pizon, MD, FACMT, Chief of Medical Toxicology Division, Professor of Emergency Medicine, University of Pittsburgh, Pittsburgh, PA
Moderator: Emily Kiernan, DO, FACEP, Assistant Professor, Emory University, Atlanta, GA
9:45 - 10:30 AM
ACMT Career Achievement Award
10:30- 11:30 AM - Poster Session 2
10:40 - 11:20 AM - Moderated Poster Forum 2
11:30 - 1:00 PM - Break / Committee Meetings
1:00 - 2:00 PM
AACT Panel | TBA
Developed in Collaboration with the American Academy of Clinical Toxicology (AACT).
2:00 - 3:30 PM - MedTox Case Panel: Case-Based Conundrums
3:30 - 5:00 PM - MTF Shark Tank Research Forum
5:00 - 7:00 PM - Open Mic Competition
Sunday, April 2, 2023
7:50 - 8:00 AM - Morning Announcements
8:00 - 9:00 AM - Lightning Oral Session
9:00 - 10:45 AM
Developed in Collaboration with the Middle East & North Africa Clinical Toxicology Association (MENATOX), Asia Pacific Association of Medical Toxicology (APAMT), and the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT).
10:45 - 11:00 AM - Break (15 min)
11:00 - 12:00 PM
ASAM Panel | NIDA Research & ED Experience with XR Injectable Buprenorphine
Kristen Huntley, PhD, Associate Director, Addiction Medicine Team Leader, Center for the Clinical Trials Network, National Institute on Drug Abuse, NIH, DHHS, Washington, DC
Gail D'Onofrio, MD, MS, Albert E. Kent Professor of Emergency Medicine, Professor of Epidemiology (Chronic Diseases) and Professor of Medicine Core Addiction, Yale School of Medicine, New Haven, CT
Joseph Carpenter, MD, Assistant Professor, Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA
Jon Cole, MD, FACMT, Emergency Physician and Medical Toxicologist, Hennepin County Medical Center; Medical Director, Minnesota Poison Control System, Minneapolis, MN
Timothy Wiegand, MD, FACMT, FAACT, DFASAM, Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY
Developed in Collaboration with the National Institute on Drug Abuse (NIDA) and the American Society of Addiction Medicine (ASAM).
12:00 - 12:45 PM
Achieving Health Equity in the Field of Substance Use: A Public Health Approach
Carla Foster, MPH, Epidemiologist and Principal Investigator, New York City Department of Health and Mental Hygiene, New York, NY
12:45 - 1:45 PM - Poster Session 3
12:55 - 1:35 PM - Moderated Poster Forum 3
Hassan Al Balushi, MD, OMSB-EM
Emergency Medicine Consultant and Medical Toxicologist
Suhar Hospital, Minitry of Health
Dr. Hassan is an Emergency Medicne Consultant and Medical Toxicologist From Oman, Completed his Medical Degree at Sultan Qaboos University Medical School in Oman in 2013. Completed his Emergency Residency Program and Board at Oman Medical Specialty Board (OMSB), Oman. Completed a 2 year fellowship program in Medical Toxicology at Emory University, Georgea, USA. Dr. Al Balushi is an active member of Middle East and North Africa Medical Toxicology Association (MENATOX), as well as a board member and the secretary of Oman Society of Emergency Medicine (OSEM).
Noah Berland, MD, MS
Assistant Division Director Medical Toxicology
Kings County Hospital
Dr. Noah Berland is an emergency physician and assistant division director of medical toxicology at NYC H+H Kings County Hospital Center. Prior to studying Medicine Dr. Berland obtained a Bachelors and Masters in Electrical Engineering. Dr. Berland obtained his MD from NYU School of Medicine and completed his Emergency Medicine Residency at SUNY Downstate - Kings County Hospital. Dr. Berland went on to complete his Medical Toxicology Fellowship and Rutgers NJMS in Newark NJ.
Albert Burgess-Hull, PhD
Head Data Scientist, SUDx/MATClinics
University of Maryland
Albert Burgess-Hull is a Data Scientist and Machine Learning Researcher at MATClinics, an outpatient addiction treatment center in Maryland that specializes in Opioid Addiction Treatment. He received his PhD from the University of Wisconsin - Madison and completed postdoctoral fellowship training at the National Institute on Drug Abuse’s Intramural Research Program. Albert’s research focuses on the development and validation of digital diagnostic and prognostic frameworks for the classification and prediction of treatment related outcomes in addiction medicine. He is also interested in how the use of advanced clustering/segmentation methodologies can be used for the development of precision medicine frameworks to deliver the optimal treatment to the right patient at the right time.
Betty Shuk Han Chan, MBBS, PhD
Prince of Wales Hospital
A/Prof Betty Chan is a clinical toxicologist and emergency physician with major interests in cardiovascular drug poisonings, antidotes and cognitive function following poisoning. She is an Associate Professor with the University of New South Wales – Head of the Discipline of Critical Care, a consultant with the NSW Poisons Information Centre and an associate Editor of the journal Clinical Toxicology. She is an emergency physician, head of the Clinical Toxicology unit at Prince of Wales Hospital, South Eastern Area Toxicology Service (SEATS). Her research findings have led to a change of clinical guidelines in the use of digoxin-Fab in acute and chronic digoxin poisonings, folinic acid in acute and chronic methotrexate poisoning. She has initiated a number of projects which have provided clinical data for further studies in tapentadol poisoning, the use of haemodialysis for acute and chronic lithium poisoning, digoxin-Fab supply and demand, optimal methods to manage severe tricyclic antidepressant and dihydropyridine poisonings.
John Downs, MD, MPH
Associate Professor and Associate Program Director
Occupational & Environmental Medicine Residency, Uniformed Services University
John W. Downs, MD, MPH is a graduate of the Virginia Military Institute and served two years as a US Army infantry officer, prior to attending medical school at the Uniformed Services University of the Health Sciences (USU). Dr. Downs completed residency training in internal medicine at Tripler Army Medical Center, Honolulu, Hawaii, and in occupational & environmental medicine at USU, where he also completed a Master of Public Health (MPH) degree. Dr. Downs later completed fellowship in medical toxicology at the Virginia Commonwealth University Health System-Medical College of Virginia. Dr. Downs is currently stationed at the Uniformed Services University where he is an Associate Professor and the Associate Program Director for the occupational and environmental medicine residency, and an attending physician at Walter Reed National Military Medical Center. Dr. Downs is board certified in internal medicine, occupational medicine, and medical toxicology, and is a certified public health professional (CPH). He is a Fellow of the American College of Physicians, and the American College of Occupational and Environmental Medicine.
Albert Garcia-Romeu, PhD
Associate Professor, Behavioral Pharmacology Research Unit
Johns Hopkins University
Albert Garcia-Romeu, Ph.D. is an Associate Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. His current research interests include clinical applications of psychedelics, real-world drug use patterns, diversity in science, and the role of spirituality in mental health. He is a founding member of the Johns Hopkins Center for Psychedelic and Consciousness Research and the International Society for Research on Psychedelics. He serves on the Board of Directors for the College on Problems of Drug Dependence (CPDD) and is an Associate Editor for the journal Psychedelic Medicine.
Richard Hamilton, MD, MBA, FACMT, FACEP, FAAEM
Professor and Chair of Emergency Medicine
Drexel University College of Medicine
Dr. Hamilton is Professor and Chair, Emergency Medicine, Drexel University College of Medicine. He is the Chief Academic Officer, DIO, and Regional Associate Dean for the Crozer Keystone Campus and EM System Chair of the Crozer Keystone Health System. Dr. Hamilton's research interests include PFAS and Manganese drinking water standards. He has received awards for his teaching and research and is a widely published author of manuscripts, textbooks, and book chapters, and patents.
Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP
Director of Occupational Medicine
Dr. Holland is the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees.
Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and at the Onondaga County Medical Examiner’s Office-both in Syracuse, NY.
He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.
Geoff Isbister, MD
Professor, School of Medicine and Public Health
University of Newcastle
I am a Professor and NHMRC Senior Research Fellow at the University of Newcastle. I am a consultant clinical toxicologist and emergency physician, Director of the Department of Clinical Toxicology, Calvary Mater Hospital and consultant toxicologist to the NSW Poisons Information Centre. I was made a Member of the Order of Australia in 2019 for my contribution to toxicology. I am President Elect of the Asia Pacific Assocation of Medical Toxicologists. My major area of research is snake bite. I have published over 375 papers and received $20 million in research funds.
Emily Kiernan, DO
Assistant Professor of Emergency Medicine and Medical Toxicology
Emory University School of Medicine
Dr. Kiernan is an Assistant Professor at Emory University School of Medicine. She is a board-certified Emergency Medicine physician who recently completed a medical toxicology fellowship at Emory University/CDC. She has served as the fellow co-chair for the AACT Radiation Special Interest Section group as well as a chair in the ACMT Fellow-in-training association.
Kathryn Kopec, DO, FACMT
Associate Professor, Division Director of Medical Toxicology
Carolinas Medical Center
Dr. Kathryn Kopec is currently an Associate Professor of Emergency Medicine and the Director of the Medical Toxicology Division at Carolinas Medical Center in Charlotte, NC. Dr. Kopec obtained her bachelor's degree in biology from the University of Dayton and her medical degree from Michigan State College of Osteopathic Medicine. She completed her Emergency Medicine residency and Medical Toxicology fellowship at Einstein Medical Center in Philadelphia, PA. She is currently on the ACMT Board of Directors. Academically her interests involved global toxicology, drugs of abuse, agitated delirium and toxicology education.
JoAn Laes, MD, DFASAM, FACMT
Addiction Staff Physician
Abbott Northwestern Hospital, Allina Health
JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.
Jeffrey Lai, MD
Assistant Professor of Emergency Medicine
Jeffrey Lai, MD, is an emergency physician and medical toxicologist at UMass Chan Medical School and UMass Memorial Health. He is the medical toxicology fellowship director and the clerkship director for the Introduction to Medical Toxicology elective at UMass Chan Medical School. His academic interests include medical education, the application of novel technologies to the treatment of substance use disorder, and the surveillance of impairing substances in patients with severe traumatic injuries.
Dan McCabe, MD
Clinical Associate Professor & Director, Division of Medical Toxicology
University of Iowa Hospitals & Clinics, Iowa Poison Control Center
Dr. Dan McCabe is a medical toxicologist and emergency medicine physician at the University of Iowa Hospitals & Clinics, as well as a Clinical Associate Professor of Emergency Medicine at the University of Iowa, the Director of the Division of Medical Toxicology at the University of Iowa, and the Medical Director of the Iowa Poison Control Center. Dr. McCabe received his medical degree from the University of Iowa. He completed a residency in emergency medicine at Cook County Hospital and a fellowship in medical toxicology at the Regions Hospital/Minnesota Poison Control System. Dr. McCabe has a broad range of interests including improvement of care for the poisoned patient, toxicology, addiction medicine, resource utilization, and public health.
Sean D. McCann, MD
Assistant Professor of Clinical Emergency Medicine and Medical Toxicology
University of Illinois Chicago
Charles McKay, MD, FACMT
Associate Medical Director
CT Poison Control Center, University of Connecticut School of Medicine
Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.
Elisabeth Moore, DO
Assistant Professor of Clinical Emergency Medicine
Weill Cornell Medicine
Dr. Moore is currently an Assistant Professor of Clinical Emergency Medicine and Medical Toxicology at Weill Cornell Medicine in New York City. She completed her Emergency Medicine Residency training at Lehigh Valley Health Network in and her Fellowship in Medical Toxicology at Banner-University Medical Center in Phoenix. She is actively involved in Women in Toxicology (WiT), and helps to produce the “Tox in Ten” and “ ACMT Highlights” Podcast.
Mark Mycyk, MD, FACMT
Chair of Research
Cook County Health
Dr. Mycyk currently serves as the Chair of Research for the Department of Emergency Medicine at Cook County Health. He is a board member of several biomedical journals, including service as Editor-in-Chief of Journal of Medical Toxicology and Associate Editor of Academic Emergency Medicine. Dr. Mycyk received an AB in English and American Literature and Language from Harvard College and an MD from University of Illinois. He completed his Residency in Emergency Medicine at Boston City Hospital/Boston Medical Center and his fellowship at Toxikon Consortium.
Nicholas Nacca, MD
Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Associate Fellowship Director of Medical Toxicology Fellowship Program
University of Rochester Medical Center
Dr. Nacca was born Rochester NY. He completed his undergraduate work at University of Rochester with a Bachelor of Science in Neuroscience. He completed medical school, Emergency Medicine residency training, and Medical Toxicology fellowship at SUNY Upstate Medical University and the Upstate Poison Control Center. He currently works as an Emergency Physician and Medical Toxicologist at University of Rochester Medical Center where he serves as the Director of Medical Toxicology. The Medical Toxicology consult service at URMC provides 24/7 call coverage for Strong Memorial Hospital and affiliates, fielding both inpatient and outpatient consultations for management of both intentional and unintentional ingestions, overdoses, and environmental exposures. Dr. Nacca’s focus is on Medical Toxicology and Emergency Medicine education, with interest in novel psychoactive substances and adulterated drugs of abuse.
Daniel Nogee, MD, MHS
Chief of Consultation, Chemical Casualty Care Division
U.S. Army Medical Research Institute of Chemical Defense
Dr. Daniel Nogee is a board-certified medical toxicologist and emergency medicine physician currently serving as the Chief of Consultation within the Chemical Casualty Care Division (CCCD) of the United States Army Medical Research Institute of Chemical Defense (USAMRICD). Dr. Nogee earned his medical degree from the Johns Hopkins University School of Medicine. While in medical school, he completed a research year at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health campus in Bethesda, MD through the Medical Research Scholars Program. Dr. Nogee completed internship and residency in emergency medicine at Yale-New Haven Hospital, and completed a Masters in Health Sciences through the Yale University School of Medicine as well as a research fellowship in emergency medicine as part of the Yale Emergency Scholars program. Dr. Nogee completed fellowship training in Medical Toxicology through the Emory University School of Medicine-Centers for Disease Control and Prevention (CDC) Medical Toxicology Fellowship in Atlanta, GA. While serving as a medical officer for the CDC’s National Center for Environmental Health he was deployed as a field investigator for an outbreak of non-viral hepatitis in the Las Vegas area.
During medical school, Dr. Nogee commissioned as an officer in the United States Army/Maryland Army National Guard. He is currently assigned as a Field Surgeon with the 224th Medical Company (Area Support) in Olney, MD. During 2020 he deployed in support of COVID-19 response efforts in Maryland. In 2021, he deployed to the Middle East as a Battalion Surgeon with the 29th Infantry Division Headquarters and Headquarters Battalion.
Anthony Pizon, MD, FACMT
Chief of Medical Toxicology Division, Professor of Emergency Medicine
University of Pittsburgh
Dr. Anthony (Tony) Pizon received his medical degree from the University of Toledo School of Medicine in 2001. He then completed his Emergency Medicine Residency at the University of Pittsburgh Medical Center in 2004 and his Medical Toxicology Fellowship at Banner Good Samaritan Medical Center in Phoenix, Arizona in 2006. Dr. Pizon is currently a Professor in the Department of Emergency Medicine, Division of Medical Toxicology at the University of Pittsburgh, School of Medicine. He serves as Chief of the Division of Medical Toxicology and Director of the Medical Toxicology Fellowship at UPMC. He is also Assistant Medical Director of both the Pittsburgh and West Virginia Poison Centers. Yet, most importantly, he is blessed with amazing wife, Caryn, and four wonderful children (Benjamin, Elizabeth, Gabriela, and Seraphina).
Robert C. Pueringer, MD
Medical Toxicologist and Addiction Medicine Specialist
Dr. Robert “Cole” Pueringer is a Medical Toxicologist, Addiction Medicine Specialist, and Hospitalist. He joined Essentia Health in September of 2022. He completed his medical training in the Twin Cities, including Medical School at the University of Minnesota, Internal Medicine Residency and Chief Resident year at Hennepin County Medical Center (HCMC). He received his CTropMed certification for Tropical Medicine & Travelers’ Health at the University of Minnesota. He then completed a Medical Toxicology fellowship at the Health Partners Institute/HCMC in 2021 and an Addiction Medicine fellowship at the University of Minnesota in 2022. His academic interests include medical education, Global Health, and the overlap of Medical Toxicology and Addiction Medicine. He is particularly passionate about substance use disorder - a disease that has affected many aspects of his own life – and hopes to contribute significantly to substance use treatment, education, de-stigmatization, and harm reduction in northern Minnesota.
Hannah Spungen, MD, MPH
Banner University Medical Center-Phoenix
Dr. Spungen is a second year Medical Toxicology fellow at Banner—University Medical Center Phoenix. She completed her Emergency Medicine residency at UCLA Ronald Reagan/Olive View. Her research interests include bias and spin in scientific communication, vasopressor dosing in cardiodepressant drug toxicity, and using R to explore large toxicologic data sets.
Trevonne Thompson, MD
Professor of Emergency Medicine & Medical Toxicology
University of Illinois College of Medicine/Toxikon Consortium
Dr. Trevonne M. Thompson is an attending emergency physician and medical toxicologist at UI Health and a tenured professor of Emergency Medicine and Medical Toxicology at the University of Illinois College of Medicine (UICOM). He obtained his undergraduate degree from Xavier University of Louisiana in New Orleans. After graduating with a degree in Biology and minors in Chemistry and Spanish, he attended medical school at the Feinberg School of Medicine at Northwestern University in Chicago. He served his emergency medicine residency at Cook County Hospital (now Stroger Hospital of Cook County). After serving as Chief Resident in Emergency Medicine, he completed a Medical Toxicology fellowship at the Toxikon Consortium in Chicago. Dr. Thompson is the head of the Division of Medical Toxicology within the Department of Emergency Medicine at UICOM. He leads the medical toxicology consultation service and clinic at UI Health. He is a consultant to the Illinois Poison Center and is an associate program director for the Toxikon Consortium Medical Toxicology Fellowship.
Dr. Thompson is the Associate Dean for Admissions for the University of Illinois College of Medicine. He is a past chair of the Emergency Medicine Section of the National Medical Association.
Michael Toce, MD, MS
Assistant Professor of Pediatric and Emergency Medicine
Harvard Medical School
Dr. Michael Toce completed his undergraduate studies at Carleton College where he received a B.A. in biology and biochemistry. He received a M.S. in bacteriology from the University of Wisconsin-Madison, and his M.D. from the Medical College of Wisconsin. He completed his pediatrics residency at the Boston Combined Residency Program before completing a Medical Toxicology Fellowship and Pediatric Emergency Medicine Fellowship at Boston Children's Hospital. He is currently an attending in the Boston Children's Hospital Emergency Department and works as a Medical Toxicologist at the MA/RI Poison Control Center. Dr. Michael Toce conducts research that focuses on pediatric toxicology and emergency medicine. He has published on the association of state opioid reduction policies with pediatric opioid poisonings and is currently focused on assessing the association of naloxone access laws and adolescent and young adult opioid overdose.
Michael J. Twiner, MD, PhD
Assistant Professor, Department of Emergency Medicine
Wayne State University
Dr. Twiner has studied environmental toxicology for over 20 years earning his PhD from Western University (Ontario, Canada). The main focus of his early research career involved identifying and characterizing the toxicological mechanisms of marine and freshwater algal toxins with applications towards the development of molecular and biochemical detection methods as well as assessing the health effects of these toxins on marine mammals and humans. He spent several years working at the National Oceanic and Atmospheric Administration’s Center for Coastal Environmental Health and Biomolecular Research in Charleston, SC before developing his own research laboratory at the University of Michigan. He continued to carry on his research program while completing his medical degree and then residency in Emergency Medicine at Detroit Receiving Hospital, Detroit, MI USA. He is now an attending physician at Detroit Medical Center, Detroit, Michigan. He holds an academic position with Wayne State University where he continues his algal toxin research but has also branched out to work on research projects involving hypertension and heart failure in the underserved communities within and around Detroit. To date, he has published over 40 research papers.
Stephanie Weiss, MD, PhD
Staff Clinician, Translational Addiction Medicine Branch
National Institute on Drug Abuse
Dr. Stephanie Weiss is the Staff Research Physician serving the Translational Addiction Medicine Branch of the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011. She is board certified in emergency medicine, addiction medicine, and medical toxicology and was selected to participate in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA. Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the TAMB mission conducting inpatient and outpatient proof-of-concept human laboratory studies. Her research interests include novel psychoactive substances, medication misuse, and improving interpretation of urine drug testing.
David Jang, MD, MSc, FACMT
University of Pennsylvania School of Medicine
We are interested in studying the interaction of mitochondrial function in the area of acute care that includes sepsis and acute poisoning. We are currently taking a translational approach studying the mitochondria at a cell-based level, to various animal models, all the way to the clinical setting actively enrolling patients with these acute medical conditions with the goal to develop better prognostic measures with the potential for mitochondrial-directed therapy.
Our lab has the latest models of the O2k-FluoRespirometer (O2k-Series H), Western blotting, confocal microscopy to study mitochondrial function in both in vitro and in vivo models with a focus on mitochondrial-directed therapies using substrate prodrugs. Relevant in vivo platforms include zebrafish, murine and porcine models of acute critical care illnesses that also combine state of the art physiological monitoring such as PV loop catheters providing realtime physiological data to be linked with cellular function. Our other interests also utilize the use of blood cells as proxy of organ cellular function as a type of biomarker which may provide prognostic function and allow clinicians to better gauge response to therapy.
Combining these elements we aim to better understand the complex interactions of both bioenergetics in issues of acute care to better improve patient care and outcomes.
- Access to the in-person event on April 12-14, 2024
- Access to the on-demand recordings (if provided by speaker) for 90 days after the event.
- Access to the Speaker slides
- Downloadable Certificate of Attendance
|ACMT Member Rates||Early-Bird
Expires: Feb 20, 2024
Begins: Feb 21, 2024
Member Tier I: Full, Affiliate, International, Emeritus
Member Tier II: Fellows
Member Tier III: Residents, International - Developing Country
Member IV: Medical Students
Expires: Feb 20, 2024
Begins: Feb 21, 2024
Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"
Non-member Tier II: Fellows, SPIs, Nurses, etc.
Non-member Tier III: Educators & Emergency Responders
Non-member IV: Residents & Students
Early-bird rates expire at midnight on FEBRUARY 20, 2024. Fees increase to the Regular Rate after this date, no exceptions.
Continuing Education credit for this activity is available for an additional fee and is provided by AKH Inc., Advancing Knowledge in Healthcare. The activity is accredited for both live and enduring participation for the following:
- Physicians (Continuing Medical Education)
- Pharmacists (Continuing Pharmacy Education)
- Nurses (Continuing Nursing Education)
Event registration cancellations received on or before February 25, 2024 (2/25/24) will receive a full refund less a 8% processing fee. Cancellations received between February 26, 2024 and March 26, 2024 (2/26/24-3/26/24) will receive a 50% refund. Cancellations made on or after March 27, 2024 (3/27/24) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.
All cancellation requests must be made in writing and emailed to: email@example.com. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.
Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to firstname.lastname@example.org. Because each exception must undergo a review and approval process, we ask in advance for your patience.
Write to: email@example.com
Continuing Education credit for this activity will be provided by AKH Inc., Advancing Knowledge in Healthcare.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
CME, CPE, and CNE Continuing Education credits are pending for this activity. It is expected that learners will receive up to 21.50 Interprofessional Continuing Education (IPCE) credit for learning and change.
The 2024 ACMT Annual Scientific Meeting will take place at the Omni Shoreham Hotel in Washington, DC.
Omni Shoreham Hotel
2500 Calvert St NW
Washington, DC 20008
ACMT has secured a discounted rate for attendees of our 2024 ACMT Annual Scientific Meeting. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!
Exclusive hotel rate expires: March 18, 2024
The landmark Omni Shoreham Hotel is located in Washington D.C.’s premier "Woodley" residential neighborhood. An icon among hotels in Washington, D.C., the Omni Shoreham Hotel has hosted presidents, world leaders and inaugural balls since its inception in the 1930s. Hotel amenities include a heated resort pool, relaxation gardens, a state-of-the art fitness center, and a massage therapy spa. The city’s most popular attractions are also nearby - including the National Zoo, the White House, the United States Capitol and the National Mall.